MedTrace Logo

Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise

NCT06520800 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-07-29

No results posted yet for this study

Summary

The main objective of this project is to analyze the effect of a tailor-made, one-to-one, exercise program (aiming to treat and handle obesity-related comorbidities in adolescents with severe obesity at high risk of cardiovascular disease development) on BMI z-score, specific comorbidities, and other health-related indicators.

This project will further allow to analyze the long-term impact of the exercise program not only on clinical parameters, but also on the interaction with drug-treatment, health-related behaviors, and quality of life, further contributing to the understanding of the individual characteristics associated with a positive exercise response and frequency.

The secondary objective of the THOR-X project is to build an educational toolkit, based on project results and relevant literature, addressed to health and exercise professionals, in order to improve management of adolescents with obesity, in particular those with severe obesity.

Conditions

  • Adolescent Obesity
  • Hypertension,Essential
  • Non-Alcoholic Fatty Liver Disease
  • Dyslipidemias
  • Metabolic Disease
  • Metabolic Syndrome

Interventions

BEHAVIORAL

Treatment and handling obesity-related comorbidities in adolescents through exercise

Tailor-made, one-to-one, physical exercise program

Sponsors & Collaborators

  • Lusofona University

    collaborator OTHER

  • University of Lisbon

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2028-12-31
Completion
2028-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06520800 on ClinicalTrials.gov